ETH-LAD

ETH-LAD, short for 6-ethyl-6-nor-lysergic acid diethylamide, is a psychedelic drug and an analog of LSD (lysergic acid diethylamide). It is known for its psychedelic effects similar to those of LSD, although users report that its effects can be somewhat different in nature and intensity. ETH-LAD was first synthesized by a team of chemists led by Alexander Shulgin, and its synthesis and effects are documented in Shulgin's book TiHKAL (Tryptamines I Have Known And Loved).
Chemistry[edit]
ETH-LAD is a member of the lysergamide family, which is a group of compounds structurally related to the ergoline family. It differs from LSD by the substitution of an ethyl group for the methyl group at the nitrogen atom of the polycyclic indole group of LSD. This slight chemical modification significantly alters the pharmacological activity of the compound, making it a unique entity among the lysergamides.
Pharmacology[edit]
The pharmacological action of ETH-LAD is primarily through agonism of the serotonin receptors in the brain, particularly at the 5-HT2A receptor. This action is similar to other psychedelics like LSD, psilocybin (found in psychedelic mushrooms), and mescaline (found in peyote). However, the exact pharmacological profile of ETH-LAD may include differences in receptor binding affinity and activity, which could explain the variations in the subjective experiences reported by users.
Effects[edit]
Users of ETH-LAD report a range of psychedelic effects including visual hallucinations, altered thinking processes, an altered sense of time, and spiritual experiences. The intensity and duration of these effects can vary based on the dose, the individual's physiology, and the setting in which the drug is consumed. Some users have reported that the effects of ETH-LAD are more visual and less introspective compared to LSD.
Legality[edit]
The legal status of ETH-LAD varies by country. In some countries, it is a controlled substance, making its manufacture, distribution, and possession illegal. In others, it remains unregulated, occupying a legal gray area that allows for its sale and use. The legal landscape is constantly evolving, with many countries moving to control substances like ETH-LAD as they become more widely known.
Safety[edit]
As with all psychedelic drugs, the safety profile of ETH-LAD depends on a variety of factors including dosage, individual sensitivity, and the setting in which it is used. There is limited scientific research on the long-term health effects of ETH-LAD, and most information comes from anecdotal reports. Users are advised to exercise caution, particularly with regard to dosage and the potential for unpredictable psychological effects.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
